IL6 and autoimmune disease: The impact of immunotherapeutic agents targeting specific genes, such as anti-IL-7R 13, anti-IL-6 15 and immune checkpoint inhibitors 16, their effect on cancer and autoimmune diseases is receiving extensive scrutiny.